Cavos Biotech LTD Information

caVos Biotech is a VC-backed company leveraging comparative genomics and AI to uncover novel mRNA therapeutics targeting longevity related indications such as fibrosis, tissue regeneration and cancer. We are pioneering a multi-layer computational algorithm to unlock the genetic basis of extraordinary, naturally occurring “super traits” that underlie disease- and age-fighting mechanisms perfected through evolution across multiple, independent animal species. Our platform translates nature’s proven evolutionary defenses into first-in-class therapeutic candidates. By integrating comparative genomics with rigorous experimental validation, we accelerate new target and drug discovery through systematically identifying and validating biologically effective, cross-species protein variants that have been conserved through evolution and drive superior cellular metabolism. Our "Longevity Atlas" contains a battery of promising candidates, some of which we have taken forward to POC validation experiments.